Skip To Content

Participating in open and frank conversations can be a catalyst for both positive change and a better industry. As we share our perspective you will find:

  • Relevant and timely industry information
  • Medication trends, and their impact
  • Case studies, and the results of their related projects
  • Special-subject on-demand webinars

Articles and blogs 

Sharing information with the industry is an important part of our mission. Our subject matter experts translate today’s news into comprehensive informational pieces to help you better understand the impact of a recent industry update, trend, or issue.

March 18, 2020 · From the desk of David W. Young
Given the recent developments and extensive news coverage about COVID-19, we understand the heightened concerns of our clients, partners and injured persons. At Optum Workers’ Comp and Auto No-Fault, our top priorities are the health and wellbeing of those we serve and the safety of those who deliver care; and we stand ready to support your needs during these challenging times.  Our dedicated employees have rigorously planned and tested our processes, systems and supply chains for business continuity, resiliency and recovery to do everything possible to support the health of those we are privileged to serve. Read more...
March 13, 2020 · Optum Settlement Solutions
A large decrease in the price of meloxicam (generic formulation of Mobic) ― a non-steroidal anti-inflammatory (NSAID) commonly prescribed for workers’ compensation injuries ― is reflected in recent updates in RED BOOK®. Read more...
March 04, 2020 · Clinical Connection team
The novel coronavirus (COVID-19), that began to emerge in late 2019, has become an increasing public health concern due to its ease of person-to-person transmission. Read more...
March 04, 2020 · Policy Matters team
The New York Workers’ Compensation Board (WCB) is hosting two free online Q&A webinars to update stakeholders on changes with the CMS-1500 Read more...
March 03, 2020 · Optum Settlement Solutions
Medications comprise a large proportion of Workers’ Compensation Medicare Set-Aside Arrangements (WCMSAs). And, as the population ages, more claimants will become eligible for Medicare coverage. So, it is important to stay up-to-date on medication costs and how they affect WCMSAs. Read more...
February 27, 2020 · Clinical Connection team
Voltaren Gel 1% (diclofenac sodium topical gel) ― a common medication in workers’ compensation and auto no-fault ― will soon transition from prescription (Rx) to over-the-counter (OTC) status, according to the U.S. Food and Drug Administration (FDA). Read more...
<< Previous      Next >>
Page 2 of 12

Subscribe today to receive our latest blogs, articles and more.